Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delayed Gastric Emptying in Functional Dyspepsia.

Vincenzo Stanghellini1, Roberto De Giorgio, Giovanni Barbara

  • 1Department of Internal Medicine and Gastroenterology and Department of Pharmacology, University of Bologna, Bologna, Italy, National Health Service, Porretta Terme (Bologna), Italy. vstang@med.unibo.it

Current Treatment Options in Gastroenterology
|July 9, 2004
PubMed
Summary

Functional dyspepsia treatment is uncertain due to complex causes. Prokinetic drugs targeting gastrointestinal motility and sensitivity show potential, but further research is needed for effective, subgroup-specific therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of a Multicomponent Formulation: A Prospective Observational Study in Patients with Gastroesophageal Reflux Symptoms.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Major Adverse Cardiac Events with Ondansetron: The Role of Observational Evidence to Inform Actionable Safer Prescribing in Cardio-Oncology.

Clinical pharmacology and therapeutics·2026
Same author

Learning planetary health through international & interprofessional education: a qualitative study of student reflections.

Medical education online·2026
Same author

High-Frequency Miniprobe Endoscopic Ultrasonography Across the Gastrointestinal Tract.

Diagnostics (Basel, Switzerland)·2026
Same author

Distinct pain profiles across irritable bowel syndrome subtypes: results from the Rome Foundation Global Epidemiology Study.

Internal and emergency medicine·2026
Same author

Comparative Study on Burden, Features and Determinants of Disorders of Gut-Brain Interaction Between Southern Europe and the Rest of Continent: Results From the Rome Foundation Global Epidemiology Study.

United European gastroenterology journal·2026

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Functional dyspepsia (FD) presents complex pathophysiology with unclear therapeutic strategies.
  • Abnormalities in gastrointestinal motility and sensitivity are implicated in a significant patient subgroup.
  • Current treatments face challenges due to limited efficacy and understanding of underlying mechanisms.

Purpose of the Study:

  • To review current therapeutic approaches for functional dyspepsia.
  • To explore the role of prokinetic agents and other drug classes in managing FD symptoms.
  • To highlight the need for targeted therapies based on specific pathophysiological abnormalities.

Main Methods:

  • Review of existing literature on functional dyspepsia pathophysiology and treatment.
  • Analysis of drug classes including antidopaminergics, serotonin receptor agonists, motilides, and others.

Related Experiment Videos

  • Discussion of the limitations and potential of various pharmacological interventions.

    • Main Results:

    • Prokinetic drugs like antidopaminergics and 5-HT4 agonists show potential for FD treatment.
    • 5-HT3 antagonists have yielded conflicting results in FD.
    • Motilides accelerate gastric emptying but face long-term efficacy issues; kappa-opioid agonists and antidepressants require further investigation.

    Conclusions:

    • Therapeutic strategies for FD should be subgroup-specific, targeting distinct pathophysiological mechanisms.
    • Further clinical trials are essential to validate efficacy in specific patient subgroups.
    • Identifying symptom generation mechanisms will drive the development of novel and effective FD treatments.